Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
4 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
4 Mar 24
8-K
Departure of Directors or Certain Officers
10 Jan 24
8-K
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
8 Jan 24
8-K
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
8 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
6 Sep 23
8-K
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
7 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
8-K
Departure of Directors or Certain Officers
28 Jun 23
8-K
Akoya Biosciences Announces Public Offering of Common Stock
12 Jun 23
8-K
Investor Presentation June 2023
7 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
4 Mar 24
424B5
Prospectus supplement for primary offering
9 Jun 23
424B5
Prospectus supplement for primary offering
7 Jun 23
S-8
Registration of securities for employees
6 Mar 23
S-3/A
Shelf registration (amended)
16 Nov 22
S-3
Shelf registration
7 Nov 22
S-8
Registration of securities for employees
14 Mar 22
S-8
Registration of securities for employees
23 Apr 21
424B4
Prospectus supplement with pricing info
19 Apr 21
8-A12B
Registration of securities on exchange
15 Apr 21
Other
EFFECT
Notice of effectiveness
22 Nov 22
CORRESP
Correspondence with SEC
17 Nov 22
UPLOAD
Letter from SEC
14 Nov 22
EFFECT
Notice of effectiveness
16 Apr 21
CERT
Certification of approval for exchange listing
15 Apr 21
SEC STAFF
SEC staff action: Order
15 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
SEC STAFF
SEC staff action: Order
9 Apr 21
CORRESP
Correspondence with SEC
30 Mar 21
Ownership
4
John Frederick Ek
2 Apr 24
4
Frederic Pla
25 Mar 24
4
Niro Ph.D Ramachandran
25 Mar 24
4
Brian McKelligon
25 Mar 24
4
Brian McKelligon
22 Mar 24
4/A
Brian McKelligon
22 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
4
Brian McKelligon
14 Mar 24
4
ROBERT G SHEPLER
14 Mar 24
144
Notice of proposed sale of securities
13 Mar 24